# Stoneridge

Type: Company (SRI)

Source: Finance Intelligence Brief — https://getfinancebrief.com/entity/stoneridge
Canonical HTML page: https://getfinancebrief.com/entity/stoneridge

## Recent coverage (1 stories)

### Pharming Outpaces Estimates as Stoneridge Pivots to Multi-Year Guidance
2026-03-12 07:10:16 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Pharming Group N.V. exceeded revenue expectations and provided a robust 2026 outlook, signaling strong adoption of its rare disease portfolio. Conversely, Stoneridge Inc. missed top-line targets but attempted to anchor investor confidence with a new two-year strategic forecast through 2027.
Full story: https://getfinancebrief.com/story/pharming-beats-stoneridge-misses-fy26-outlook

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getfinancebrief.com/guides/methodology for the full editorial methodology.